Single-use Bioreactors Market Share To Reach Scalable Heights Of Growth

Single-use Bioreactors Market Summary

The global single-use bioreactors market size was estimated at USD 4.58 billion in 2024 and is projected to reach USD 18.65 billion by 2033, growing at a CAGR of 17.12% from 2025 to 2033. Single-use bioreactor systems are becoming a key technology for pharmaceutical production and mammalian cell culture applications, offering operational flexibility, faster deployment, and cost-effective solutions. Their adoption is particularly high in biopharmaceutical manufacturing, where the ability to scale production quickly and safely is critical to meet market demands and evolving therapeutic needs.

Single-use bioreactors are highly valued for their ability to reduce the risk of cross-contamination through comprehensive qualification and validation procedures, enhancing process safety, especially when handling highly potent biologics. These systems eliminate the need for extensive cleaning and sterilization, lowering operational costs while ensuring compliance with stringent regulatory standards. As the demand for biologics, vaccines, and cell-based therapies increases globally, single-use bioreactors offer the adaptability required to meet diverse production requirements efficiently.

Key Market Trends & Insights

• North America held the largest revenue share of 34.24% in the global single-use bioreactors market in 2024, driven by advanced pharmaceutical infrastructure, ongoing R&D activities, and early adoption of innovative biomanufacturing technologies.
• The U.S. single-use bioreactors market is projected to grow steadily from 2025 to 2033, supported by increasing investments in biologics and personalized medicine, as well as expanding production capacities.
• By product type, the single-use bioreactor systems segment dominated the market with a share of 81.19% in 2024, reflecting their widespread use in modern biomanufacturing workflows.
• By type, stirred-tank single-use bioreactors held the largest market share in 2024, owing to their versatility, ease of operation, and suitability for various cell culture processes.
• By type of cell, mammalian cells represented the largest segment in 2024, as these cells are widely used in the production of vaccines, therapeutic proteins, and other biopharmaceutical products.

Order a free sample PDF of the Single-use Bioreactors Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 4.58 Billion
• 2033 Projected Market Size: USD 18.65 Billion
• CAGR (2025-2033): 17.12%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

The market for single-use bioreactors is characterized by the presence of multiple major players, each of which uses innovation and strategic initiatives to support the industry's expansion. Prominent companies such as Thermo Fisher Scientific, Sartorius AG, and Merck KGaA provide a variety of single-use bioreactor systems, such as stirred-tank and wave-induced types, to meet the needs of different cell culture and biopharmaceutical production applications. Through partnerships and acquisitions, these businesses have increased the range of products they offer, strengthening their position in the bioprocessing solutions market. For example, the purchase of Patheon by Thermo Fisher Scientific has strengthened its position in the manufacturing and contract development industry. On the other hand, Sartorius AG's cell analysis products have been enhanced by the acquisition of Essen Bioscience.

Key Players

• Sartorius Inc.
• Thermo Fisher Scientific, Inc.
• Danaher
• Merck KgaA
• Celltainer Biotech BV
• Getinge AB
• Eppendorf AG
• Cellexus
• Lonza
• PBS Biotech Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global single-use bioreactors market is witnessing rapid growth due to increasing demand for flexible, scalable, and safe biomanufacturing solutions. North America leads in revenue share, with the U.S. driving technological adoption and expansion. Stirred-tank systems dominate due to their operational versatility, while mammalian cell applications remain the largest end-use segment. The strong focus on reducing contamination risk, lowering costs, and meeting regulatory compliance is further accelerating market adoption. Over the forecast period, growing biologics production, rising investment in personalized medicine, and the need for efficient cell culture processes will continue to drive sustained growth and innovation in the single-use bioreactors market.